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A DISEASE MANAGEMENT PROGRAM IN FRANCE: LESSONS FROM THE RESALIS EXPERIMENT 18 MONTHS BEFORE AND 12 MONTHS AFTER PUBLIC HEALTH INTERVENTIONS
Launois R 1 , Mègnigbêto AC 2 , Perez V 3 , Roy M 3 , Camus A 4 , Gailhardou M 5 , Lançon F 5 , Quéniart M 5 1 Rees, France (Réseau d'Evaluation en Economie de la Santé) Paris (France), Paris, France; 2 Rees, France, Paris, France; 3 Cpam de l'eure, Evreux, France; 4 Medical Cabinet, Beaumontle-Roger, France; 5 Alliance Medica (GSK), Marly Le Roi, France OBJECTIVES: Asthma treatments have a good benefit/risk ratio. Recent recommendations from international consensus have standardised asthmatic patients' management methods (Gina 2002) . Compliance with these standards, however, remains low: a more global management is required. Alliance Médica and a local sickness fund (Eure Department) have launched a disease management program, including education of patients and training of doctors to improve the state of health of patients suffering from asthma and reduce costs to the community. METHODS: The assessment is based on a "before-after" study (respectively 18 and 12 months). Two outcomes were assessed: control of the asthma and the quarterly cost of follow-up. The definition of control is based on the six criteria and thresholds from the Canadian asthma consensus report (1). The quarterly cost is the sum of medical expenditure and production losses for patients who had at least one follow-up consultation during each period considered. RESULTS: Forty-three doctors agreed to take part in the study, 32 of whom returned the medical information electronically. Three hundred and thirty eight patients were pre-included: 27 patients did not meet the inclusion criteria and 311 subjects were eligible. Proportion of asthmatic patients controlled over the 1-year period before the intervention was equal to 52.6% of the patients followed. After the intervention the control rate reached 67.7%. The incremental effectiveness is equal to 15%. After intervention, the standard quarterly costs were lower for both groups control and non-control: respectively €118.9 vs €152.7 and €359.9 vs €264.8. The overall rate of quarterly savings after intervention compared to the situation without intervention is equal to 32.4% (€172.1 versus €255.2). CONCLUSION: The "pragmatic" evaluation of the management of asthma in primary care with "trickle" inclusions and follow-ups requires a new statistical approach. This 1st primary network in France is a successful experiment. (1) CMAJ. Nov 30, 1999; 161 (11 suppl) .
